Trial intelligence / Profile preview

Sitagliptin prophylaxis for prednisolone-induced glucose metabolism impairment in men with metabolic syndrome

NL-OMON35611Active, not recruiting

Sponsor
Vrije University Medical Center
Start
Feb 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of sitagliptin and prednisolone in dysglycemia and Beta-cell dysfunction (4 arms), sponsored by Vrije University Medical Center. Primary endpoint: Postprandial glucose area under the curve during standardized mixed-meal test. Started Feb 2009; status: active, not recruiting.

02

Drugs

sitagliptinprednisolone
03

Conditions

dysglycemiaBeta-cell dysfunction

Beyond the preview

Go deeper on NL-OMON35611.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON35611.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call